E-LIB Suche - Ergebnisse für: Wasamoto, Satoshi

1

Efficacy and Safety of First-line Pembrolizumab Plus Platin..:

Wasamoto, Satoshi ; Imai, Hisao ; Tsuda, Takeshi...
Internal Medicine. , 2024

Link: https://doi.org/10.2169/..

2

Pretreatment glasgow prognostic score predicts survival amo..:

Wasamoto, Satoshi ; Imai, Hisao ; Tsuda, Takeshi...
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Imai, Hisao ; Wasamoto, Satoshi ; Tsuda, Takeshi...
Thoracic Cancer. 14 (2023) 25 - p. 2567-2578 , 2023

Link: https://doi.org/10.1111/..

4

Real‐world data of atezolizumab plus carboplatin and etopos..:

Ayako Shiono ; Hisao Imai ; Satoshi Wasamoto...
https://doi.org/10.1002/cam4.4938. , 2023

Link: https://doi.org/10.1002/..

5

Table_1_Pretreatment glasgow prognostic score predicts surv..:

Satoshi Wasamoto ; Hisao Imai ; Takeshi Tsuda...
doi:10.3389/fonc.2022.1080729.s001. , 2023

Link: https://doi.org/10.3389/..

6

Pretreatment glasgow prognostic score predicts survival amo..:

Satoshi Wasamoto ; Hisao Imai ; Takeshi Tsuda...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1080729/full. , 2023

Link: https://doi.org/10.3389/..

7

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Hisao Imai ; Satoshi Wasamoto ; Takeshi Tsuda...
https://doi.org/10.1111/1759-7714.15036. , 2023

Link: https://doi.org/10.1111/..

8

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Imai, Hisao ; Wasamoto, Satoshi ; Tsuda, Takeshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481141/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Efficacy and safety of amrubicin monotherapy after atezoliz..:

Imai, Hisao ; Nagai, Yoshiaki ; Minemura, Hiroyuki...
Investigational New Drugs. 40 (2022) 5 - p. 1066-1079 , 2022

Link: https://doi.org/10.1007/..

10

Predictive value of post‐treatment C‐reactive protein‐to‐al..:

Araki, Taisuke ; Tateishi, Kazunari ; Komatsu, Masamichi...
Thoracic Cancer. 13 (2022) 14 - p. 2031-2040 , 2022

Link: https://doi.org/10.1111/..

11

Real‐world data of atezolizumab plus carboplatin and etopos..:

Shiono, Ayako ; Imai, Hisao ; Wasamoto, Satoshi...
Cancer Medicine. 12 (2022) 1 - p. 73-83 , 2022

Link: https://doi.org/10.1002/..

12

Wheezing and Weightlifting:

Yanagisawa, Satoru ; Wasamoto, Satoshi ; Takechi, Hiroki.
Internal Medicine. 61 (2022) 6 - p. 931-932 , 2022

Link: https://doi.org/10.2169/..

13

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
Thoracic Cancer. 13 (2022) 19 - p. 2776-2785 , 2022

Link: https://doi.org/10.1111/..

14

Post‐progression survival after atezolizumab plus carboplat..:

Ken Masubuchi ; Hisao Imai ; Satoshi Wasamoto...
https://doi.org/10.1111/1759-7714.14621. , 2022

Link: https://doi.org/10.1111/..

15

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527159/. , 2022

Link: http://www.ncbi.nlm.nih...